Generating new business models with AI
Despite some ethical concerns, leaders must know how to tap new capabilities to transform their businesses...
Share
YouTube
Tech for Good
ESG
Bioversys: ‘Impact investors should focus more on equitable health’
With investors increasingly focusing on ESG topics, you might think that being a Tech for Good company would help attract funding. This is not always the case, says Marc Gitzinger, CEO of...
With investors increasingly focusing on ESG topics, you might think that being a Tech for Good company would help attract funding. This is not always the case, says Marc Gitzinger, CEO of Bioversys, which is developing new medicines for severe life-threatening bacterial infections that are resistant to antibiotics.
In episode five, Gitzinger says the biotech industry still focuses mainly on financial returns and calls on impact investors to pay more attention to the topic of equitable health to ensure access and proper control of good quality drugs throughout the world.
Gitzinger discusses how he defines success, including the importance of generating financial returns for the investors who have believed in the technology and backed the business.
Expert
Authors
More to explore
Corporate Digital Responsibility: the next ethical frontier
There have been two megatrends that have dominated the last decade: digitization and ethics and sustainability, but so far there have been few points of intersection between these two trends, largely because...
- YouTube
‘The data monetization trend calls for a common framework, but we need to prioritize questions of trust’
A panel of experts moderated by IMD Professor of Finance Arturo Bris, Director of the World Competitiveness Center, says governments and companies need to build citizen trust in data use....
- YouTube